The company has outstanding warrants to employees of Psyros Diagnostics Ltd. of 8,304,510 (corresponding to 83,045 shares) and 80,703 (corresponding to 80,703 shares) and can thus cause dilution.
Prolight Diagnostics’ share is traded on the NGM Growth Market, under the name PRLD.